---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-006236"
form_type: "8-K"
ticker: "IPSC"
cik: "0001850119"
company_name: "Century Therapeutics, Inc."
filed_at: "2026-01-23T23:59:59+00:00"
generated_at: "2026-05-16T08:30:28.063490+00:00"
event_type: "regulatory"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Century Therapeutics regains Nasdaq bid price compliance; reverse split not needed

## Summary
- Nasdaq notified Century on Jan 22, 2026 that it regained compliance with minimum $1.00 bid price rule.
- Stockholders approved reverse stock split (1:5–1:30) at special meeting earlier that day.
- Company will not implement the reverse split due to regained compliance.
- No other business was conducted; adjournment proposal was unnecessary.

## SEC filing metadata
- accession: 0001104659-26-006236
- form_type: 8-K
- ticker: IPSC
- cik: 0001850119
- company_name: Century Therapeutics, Inc.
- filed_at: 2026-01-23T23:59:59+00:00
- event_type: regulatory
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 5.07, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850119/000110465926006236/0001104659-26-006236-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850119/000110465926006236/tm263921d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-006236
- JSON: https://secwatch.observer/filing/0001104659-26-006236.json
- Plain text: https://secwatch.observer/filing/0001104659-26-006236.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.